je.st
news
The Wall Street Journal: Actavis set for $20 billion corporate-bond sale
2015-03-02 14:28:45| Biotech - Topix.net
Pharmaceutical company Actavis PLC is expected to sell more than $20 billion in bonds as early as this week, a deal that would rank as the second-largest corporate bond ever and further propel bond sales this year into record territory. Traders expect the bonds to fly off the shelves, with investors globally searching for income-generating investments at a time of low rates on safe government debt.
Tags: set
sale
street
journal
Category:Biotechnology and Pharmaceuticals